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Introduction and objectives 
COPD is a major cause of mortality. Patients with advanced disease often have a poor quality of life, 
such that guidelines recommend providing palliative care in their last year of life. We have recently 
shown that palliative care is only provided to one in five patients. This lack of provision maybe related 
to the difficulty in predicting 12-month mortality due to the irregular disease trajectory of COPD. 
Current index scores predict mortality over several years and often require specialist disease 
knowledge not available within primary care. We sought to devise a 12-month all-cause mortality 
prediction model only using routinely recorded information.  
Methods 
We randomised a primary care COPD cohort, identified using UK electronic healthcare records (Clinical 
Practice Research Datalink) between 2010 and 2015, into training and test datasets. A predictive 
model (PI) was developed using the training set, adopting backwards elimination Cox regression of 
putative prognostic indicators; variables previously shown to be associated with COPD mortality and 
that are routinely collected in primary care records, including demographics, respiratory variables, 
comorbidities and blood results. The test set was used to externally validate predictive performance, 
by measuring the calibration slope and discrimination performances (Harrell’s C-index and D-statistic). 
The model was compared, calculating the Area Under the Curve (AUC) in the test set, to all established 
index scores that do not require specialist information, BODEx, DOSE and ADO.  
Results 
58,056 patients were eligible. Eighteen variables were included in the model, including age, FEV1, BMI, 
smoking, hospitalised exacerbations, blood tests (haemoglobin, creatinine, albumin, platelets) and 
comorbidities (lung cancer, lung fibrosis, atrial fibrillation, asthma, chronic kidney disease, stroke, and 
dementia). Predictive performance was good (C-index=0.8, 95%CI 0.79-0.81; D-statistic=1.93, 95%CI 
1.84-2.02, calibration slope=0.92, 95%CI 0.88-0.97) and the model compared favourably to existing 
index scores (AUC: PI=0.81, 95%CI 0.79-0.82; BODEx=0.48, 95%CI 0.45-0.52; DOSE=0.6, 95%CI 0.57-
0.63; ADO=0.69, 95%CI 0.67-0.71; see Figure). 
Conclusions 
Our model performs better than existing tools in predicting 12-month mortality and only requires 
routinely collected non-specialist information. This model could help identify patients that would 
benefit from palliative care. This model also demonstrates the complexity of COPD mortality, and 
influence of comorbidities. 
 
 
 
